GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Repros Therapeutics Inc. (RPRX) [hlAlert]

Repros Therapeutics Inc. (RPRX) is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs. The Company's principal drug, Proellex,
is a selective blocker of the progesterone receptor and is being developed for the treatment of uterine fibroids, anemia associated with excessive menstrual bleeding relating to uterine fibroids, or anemia associated with uterine fibroids and endometriosis. The second product candidate, Androxal, is a single isomer of clomiphene citrate and an orally active small molecule compound.
.
( Total: 7 Current Stock Recommendations )
Repros Therapeutics Inc.   (7)
Hold Buy 86%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Buy RPRX
down 54.71 %
Repros Therapeutics Inc. (RPRX) rated Overweight by Piper Jaffray
Wednesday,  Nov 27, 2013  8:25 AM ET

Rating:
Buy RPRX
down 63.67 %
Repros Therapeutics Inc. (RPRX) rated Buy by BofA/Merrill
Tuesday,  Jul 2, 2013  8:25 AM ET

Rating:
Buy RPRX
up 70.21 %

Rating:
Buy RPRX
down 55.14 %

Rating:
Buy RPRX
down 40.19 %
Repros Therapeutics Inc. (RPRX) rated Buy by Lazard
Tuesday,  Feb 5, 2013  8:25 AM ET

Rating:
Buy RPRX
down 49.86 %
Repros Therapeutics Inc. (RPRX) upgraded to Buy by ROTH Capital
Wednesday,  Nov 21, 2012  8:25 AM ET

Rating:
Buy RPRX
up 70.21 %

Rating:
Buy RPRX
down 55.44 %

Rating:
Buy RPRX
up 70.21 %

Rating:
Buy RPRX
up 31.86 %

Rating:
Buy RPRX
up 1,656.09 %

Rating:
Hold RPRX

Rating:
Hold RPRX

Rating:
Buy RPRX
down 30.96 %

Your Recent Stocks
SymbolLastChange
RPRX 2.52 down  -65.00 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy